1-4 of 4
Authors: Victoria Birlutiu
Sort by
Journal Article
Should We Use Rifampicin in Periprosthetic Joint Infections Caused by Staphylococci When the Implant Has Been Exchanged? A Multicenter Observational Cohort Study
Tobias Siegfried Kramer and others
Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae075, https://doi.org/10.1093/ofid/ofae075
Published: 08 February 2024
Journal Article
Should We Use Rifampicin in Periprosthetic Joint Infections Caused by Staphylococci When the Implant Has Been Exchanged? A Multicenter Observational Cohort Study
Tobias Siegfried Kramer and others
Open Forum Infectious Diseases, Volume 10, Issue 10, October 2023, ofad491, https://doi.org/10.1093/ofid/ofad491
Published: 06 October 2023
Journal Article
A Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019
Jin Yong Kim and others
Open Forum Infectious Diseases, Volume 9, Issue 8, August 2022, ofac406, https://doi.org/10.1093/ofid/ofac406
Published: 08 August 2022
Journal Article
546. Therapeutic Effect of Regdanvimab in Patients with Mild to Moderate COVID-19: Day 28 Results from a Multicentre, Randomised, Controlled Pivotal Trial
Michael G Ison and others
Open Forum Infectious Diseases, Volume 8, Issue Supplement_1, November 2021, Page S375, https://doi.org/10.1093/ofid/ofab466.745
Published: 04 December 2021
Advertisement
Advertisement